Follow-up Support for Care Plan Engagement

Recruiting at 5 trial locations

Overseen By Principal Investigator

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Colorado, Denver

Must not be taking: Dementia medications

Disqualifiers: Dementia, Advanced illness, Frailty, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 12

1000 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will evaluate the impact of 3 different strategies to increase engagement of participants in My Own Health Report (MOHR) and health behavior change activities over time. This study will evaluate the level of engagement, outcomes, cost and cost-effectiveness of these strategies.

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.

Score in the 'at-risk' range on both of the following cancer risk assessments: 1) Physical activity risk: less than 150 minutes per week of moderate to vigorous physical activity; Diet risk: Less than 5 servings daily of combined fruit/vegetables

Patient at one of the participating clinics

Exclusion Criteria

I do not have any serious illnesses or dementia that would prevent me from joining the study.

My preferred language is not English or Spanish.

Incomplete or no MOHR assessment

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the MOHR intervention with R2 Message and/or R2 Navigation strategies

6 months

Maximum of 12 navigator calls and 60 text messages

Follow-up

Participants are monitored for engagement and improvement in behavioral risk factors

6 months

What Are the Treatments Tested in This Trial?

Interventions

• MOHR Follow-up Support

How Is the Trial Designed?

Group I: R2 Navigation only Experimental Treatment 2 Interventions

Reminder and Resources provided to patient via health navigator

Group II: R2 Message Only Experimental Treatment 2 Interventions

Reminder and Resources Messages sent to patient

Group III: R2 Message + R2 Navigation Experimental Treatment 3 Interventions

Both reminder and resources messages and navigation provided to the patient

Group IV: Control Arm Active Control 1 Intervention

Standardized version of usual care

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials

1,842

Recruited

3,028,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+